Trial Profile
Phase II clinical trial to determine if polyphenon E inhibits c-met signaling and activation of pathways contributing to breast cancer progression
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Polyphenon E (Primary)
- Indications Advanced breast cancer; Early breast cancer
- Focus Biomarker; Therapeutic Use
- 23 Sep 2017 Status changed from active, no longer recruiting to completed.
- 25 Oct 2012 Planned End Date changed from 1 Jul 2012 to 1 Jul 2013 as reported by ClinicalTrials.gov.
- 21 Jul 2011 Planned end date changed from 1 Jul 2010 to 1 Jul 2012 as reported by ClinicalTrials.gov.